Trajan Scientific and Medical completed the acquisition of Neoteryx LLC, a leader in blood micro-sampling devices. This acquisition will drive the global commercialization and adoption of micro-sampling at a large scale for Trajan.
Thermo Fisher Scientific Inc. acquired the leading global provider of clinical research services, PPD, Inc. for USD 17.4 billion.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 3989
Published Date: May 23, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The increasing volume of clinical trials and preclinical trials with growing research studies & development in healthcare, pharmaceutical, life science, and several other fields is estimated to boost the market growth.
The market size of micro syringes is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023-2035.
High production costs of micro syringes are estimated to be the growth hindering factors for the market expansion.
The North American market in the region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
The major players in the market are Trajan Scientific and Medical, Agilent Technologies, Inc., Shimadzu Corporation, Avantor, Inc., ITO Corporation, Merck KGaA, and Thermo Fisher Scientific Inc.
The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company
The market is segmented by type, needle type, end-user, and by region.
The removable segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.